Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D Davis

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Internal Medicine Journal|January 29, 2011
An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009S Lingaratnam, M A Slavin, L Mileshkin, et al.
Internal Medicine Journal|August 2, 2014
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyB O'Carrigan, M Fournier, I N Olver, et al.
British Journal of Cancer|April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribA J Watson, M R Middleton, G McGown, et al.
British Journal of Cancer|February 20, 2015
IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinomaC-F Xu, T Johnson, J Garcia-Donas, et al.
Cancer Epidemiology|September 25, 2021
Analgesic use and the risk of renal cell carcinoma - Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) studyF J Bruinsma, S Jordan, J K Bassett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumI Stukalin, J C Wells, J Graham, et al.
Preparative Biochemistry & Biotechnology|May 11, 2005
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditionsR Murphy, S Green, G Ritter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trialA M Scott, F T Lee, W Hopkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2025
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)H-M Lin, T Scheinberg, N Portman, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Internal Medicine Journal|January 29, 2011
An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009S Lingaratnam, M A Slavin, L Mileshkin, et al.
Internal Medicine Journal|August 2, 2014
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyB O'Carrigan, M Fournier, I N Olver, et al.
British Journal of Cancer|April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribA J Watson, M R Middleton, G McGown, et al.
British Journal of Cancer|February 20, 2015
IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinomaC-F Xu, T Johnson, J Garcia-Donas, et al.
Cancer Epidemiology|September 25, 2021
Analgesic use and the risk of renal cell carcinoma - Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) studyF J Bruinsma, S Jordan, J K Bassett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumI Stukalin, J C Wells, J Graham, et al.
Preparative Biochemistry & Biotechnology|May 11, 2005
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditionsR Murphy, S Green, G Ritter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trialA M Scott, F T Lee, W Hopkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2025
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)H-M Lin, T Scheinberg, N Portman, et al.
Pageof 6